Telix Pharmaceuticals is a dynamic, fast-growing radiopharmaceutical company with offices in Australia (HQ), Belgium, Japan, Switzerland, and the United States. Our mission is to deliver on the promise of precision medicine through targeted radiation. At our core, we exist to create products that seek to improve the quality of life for people living with cancer and rare diseases. You will be supporting the international roll-out of our approved prostate cancer imaging agent and helping us to advance our portfolio of late clinical-stage products that address significant unmet need in oncology and rare diseases.

See Yourself at Telix

The Brand Lead – Illuccix Japan is responsible for developing and executing the brand strategy and commercial launch plan for Illuccix (⁶⁸Ga-PSMA-11) in the Japanese market. This is an individual contributor role with no direct reports, requiring hands-on ownership of both strategic planning and tactical execution across all brand activities. The role encompasses market positioning, messaging, promotional material development, KOL engagement, and cross-functional collaboration with Medical Affairs, Regulatory, Market Access, and Supply & Distribution to ensure launch readiness. A strong understanding of oncology marketing, Japan's healthcare and regulatory landscape, and radiopharmaceutical commercialisation is required.

This role is critical to the successful commercial launch of Illuccix in Japan, contributing to Telix’s broader commercial expansion in the region.

Key Accountabilities

Lead the end-to-end Japan launch of Illuccix, from pre-launch preparation through commercialization, personally executing tactics where needed.
Own Japan commercial strategy including launch sequencing, channel prioritization, and payer/access narrative in coordination with Market Access.
Develop and implement a comprehensive brand strategy for Illuccix in Urologic-oncology, including positioning, messaging, and value proposition tailored to Japanese markets.
Create and produce core promotional and medical education materials (digital, print, congress) independently, without relying on agency support.
Build and maintain strong relationships with key opinion leaders (KOLs), Urologic-oncology specialists, Urologists (focused on Prostate Cancer), and Nuclear Medicine specialists across Japan.
Conduct market research and competitive intelligence to identify insights, track competitor activity, and refine brand strategy.
Collaborate cross-functionally with Medical Affairs, Market Access, Regulatory, and Sales to ensure brand cohesion and launch readiness.
Manage the brand budget directly, making hands-on decisions to optimize spending and maximize ROI.
Develop congress and event materials and represent Telix at key Urologic-oncology meetings (e.g., JUA, JSCO, JSUO).
Monitor brand performance using KPIs and sales data, identifying course-correction opportunities and adjusting tactics proactively.
Ensure all promotional materials and activities comply with Japanese regulatory and industry standards (JPMA, local codes).
Contribute to the development of patient support programs and disease awareness initiatives in Urologic-oncology.

Education and Experience

Bachelor’s degree in marketing, Business Administration, Life Sciences, or a related field required. MBA or advanced scientific degree preferred.
7+ years of experience in pharmaceutical brand management, with a minimum of 3 years in oncology or Urologic-oncology specifically.
Demonstrated experience independently owning brand launches in Japan, including content creation, KOL engagement, and congress presence — with accountability for launch outcomes.
Prior experience in radiopharmaceuticals — either diagnostic (e.g., PSMA PET, PET/SPECT imaging agents) or therapeutic (e.g., targeted radionuclide therapy, RLT/theranostics) — is strongly preferred and will be a key differentiator for candidates.
Hands-on proficiency with marketing tools and platforms (e.g., Veeva PromoMats, Adobe suite, digital marketing platforms, CRM systems).